Association between phosphate removal and markers of bone turnover in haemodialysis patients

被引:26
|
作者
Albalate, Marta
de la Piedra, Concepcion
Fernandez, Cristina
Lefort, Mar
Santana, Henar
Hernando, Paloma
Hernandez, Jesus
Caramelo, Carlos
机构
[1] Univ Autonoma Madrid, Hosp Clin, Serv Nefrol & Bioquim, Fdn Jimenez Diaz, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp Clin, Serv Epidemiol, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
关键词
bone turnover; haemodialysis; osteoprotegerin; phosphate removal; PTH; RANKL;
D O I
10.1093/ndt/gfl034
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD. Methods. Blood samples for serum Ca, phosphate, bicarbonate, intact PTH, PTH (1 - 84), bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, OPG and receptor activator of nuclear factor-kappa B ligand ( RANKL) were obtained in 28 HD patients. Phosphate removal was measured by a continuous collection of the dialysate. Results. Pre-dialysis serum phosphate concentration is the critical factor in determining dialytic phosphate removal. However, multiple regression analysis reveals that phosphate removal is better explained by a combination of factors than by phosphate concentration alone. In this model, the PTH/OPG ratio is an additional positive factor, whereas age and vitamin D treatment are negative factors. Patients with pre-HD bicarbonate higher than 20 mEq/l had higher serum phosphate and, accordingly, higher phosphate removal; of interest, these individuals also have significant differences in RANKL/OPG. Mean (SD) OPG levels were significantly higher than that in the healthy population (16.2 ( 12.5) pmol/ l; these values correlated with age (r = 0.4, P < 0.04). Mean serum RANKL (1.03 (1.02) pmol/l) was within the range of normal individuals. Conclusions. Dialytic phosphate removal has a crucial, direct relationship with pre-HD plasma phosphate levels. However, the phenomenon of phosphate removal is more precisely explained using a more complex relationship, defined by the interaction between serum phosphate, PTH/ OPG, age and vitamin D administration. Serum RANKL levels are first reported in HD patients, and are not different from the normal population.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
  • [21] Biochemical markers of bone turnover and their association with bone marrow lesions
    Hunter, David J.
    LaValley, Michael
    Li, Jiang
    Bauer, Doug C.
    Nevitt, Michael
    DeGroot, Jeroen
    Poole, Robin
    Eyre, David
    Guermazi, Ali
    Gale, Daniel
    Totterman, Saara
    Felson, David T.
    ARTHRITIS RESEARCH & THERAPY, 2008, 10 (04)
  • [22] Markers of bone turnover in patients with nephrolithiasis
    Kuczera, M
    Wiecek, A
    Kokot, F
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1997, 26 (02) : 81 - 84
  • [23] Markers of bone turnover in patients with nephrolithiasis
    Kuczera M.
    Wiecek A.
    Kokot F.
    International Urology and Nephrology, 1997, 29 (5) : 523 - 528
  • [24] Markers of bone turnover in patients with nephrolithiasis
    Kuczera, M
    Wiecek, A
    Kokot, F
    TRACE ELEMENTS AND ELECTROLYTES, 1997, 14 (02): : 58 - 60
  • [25] Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis
    Gamez-Nava, J. I.
    de la Cerda-Trujillo, L. F.
    Vazquez-Villegas, M. L.
    Cons-Molina, F.
    Alcaraz-Lopez, M. F.
    Zavaleta-Muniz, S. A.
    Rocha-Munoz, A. D.
    Martinez-Garcia, E. A.
    Corona-Sanchez, E. G.
    Salazar-Paramo, M.
    Fajardo-Robledo, N. S.
    Olivas-Flores, E. M.
    Cardona-Munoz, E. G.
    Gonzalez-Lopez, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (06) : 480 - 490
  • [26] Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients
    Dede Sit
    Ali Kemal Kadiroglu
    Hasan Kayabasi
    A. Engin Atay
    Zulfukar Yilmaz
    M. Emin Yilmaz
    Advances in Therapy, 2007, 24 : 987 - 995
  • [27] The relationship between bone mineral density and biochemical bone turnover markers in hemodialysis patients
    Sit, D
    Kadiroglu, AK
    Kayabasi, H
    Atay, AE
    Yilmaz, ME
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A56 - A56
  • [28] Relationship between bone mineral density and biochemical markers of bone turnover in Hemodialysis patients
    Sit, Dede
    Kadiroglu, Ali Kemal
    Kayabasi, Hasan
    Atay, A. Engin
    Yilmaz, Zulfukar
    Yilmaz, M. Emin
    ADVANCES IN THERAPY, 2007, 24 (05) : 987 - 995
  • [29] Evaluation of bone mineral density and markers of bone turnover in men on haemodialysis and after renal transplantation
    Kurnatowska, Ilona
    Zygmunt, Arkadiusz
    Kacprzyk, Feliks
    Nowicki, Michal
    Lewinski, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 524 - 524
  • [30] Association between sclerostin, serum bone turnover markers and bone density in postmenopausal women with fragility fracture
    Zou, Jian
    Li, Xiaolin
    Yang, Fan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 12984 - 12991